Related Experiment Video
Updated: Aug 25, 2025

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
PRELP Regulates Cell-Cell Adhesion and EMT and Inhibits Retinoblastoma Progression
Jack Hopkins1, Ken Asada2,3, Alex Leung1
1UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.
Abstract:
Retinoblastoma (RB) is the most common intraocular pediatric cancer. Nearly all cases of RB are associated with mutations compromising the function of the RB1 tumor suppressor gene. We previously demonstrated that PRELP is widely downregulated in various cancers and our in vivo and in vitro analysis revealed PRELP as a novel tumor suppressor and regulator of EMT. In addition, PRELP is located at chromosome 1q31.1, around a region hypothesized to be associated with the initiation of malignancy in RB. Therefore, in this study, we investigated the role of PRELP in RB through in vitro analysis and next-generation sequencing. Immunostaining revealed that PRELP is expressed in Müller glial cells in the retina. mRNA expression profiling of PRELP mouse retina and PRELP-treated RB cells found that PRELP contributes to RB progression via regulation of the cancer microenvironment, in which loss of PRELP reduces cell-cell adhesion and facilitates EMT. Our observations suggest that PRELP may have potential as a new strategy for RB treatment.
Insights
PRELP acts as a tumor suppressor in retinoblastoma (RB), a common pediatric eye cancer. Loss of PRELP promotes cancer progression by reducing cell adhesion and increasing EMT, suggesting PRELP as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Retinoblastoma (RB) is the most common intraocular pediatric cancer, often linked to mutations in the RB1 tumor suppressor gene.
- PRELP, previously identified as a tumor suppressor regulating EMT, is located near a chromosomal region associated with RB initiation.
- PRELP expression is downregulated in various cancers, indicating its potential role in tumorigenesis.
Purpose of the Study:
- To investigate the role of the PRELP gene in the development and progression of retinoblastoma.
- To explore PRELP's function as a tumor suppressor within the context of RB.
- To identify potential therapeutic strategies targeting PRELP for RB treatment.
Main Methods:
- In vitro analysis of RB cells.
- Next-generation sequencing.
- Immunostaining to detect PRELP expression in retinal Müller glial cells.
- mRNA expression profiling in mouse retina and RB cells.
Main Results:
- PRELP is expressed in Müller glial cells in the retina.
- Loss of PRELP in RB cells reduces cell-cell adhesion.
- Downregulation of PRELP facilitates epithelial-mesenchymal transition (EMT) in RB.
- PRELP influences the cancer microenvironment, impacting RB progression.
Conclusions:
- PRELP functions as a tumor suppressor in retinoblastoma.
- PRELP's regulation of cell adhesion and EMT is crucial in RB progression.
- PRELP represents a potential novel therapeutic target for retinoblastoma treatment.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Abnormal Proliferation
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Replicative Cell Senescence

